◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeAll stocks0-9 › 2251

Beijing Airdoc Technology Co., Ltd. (2251) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Health Information Services · DATA UPDATED 2026-08-11

Beijing Airdoc Technology Co., Ltd. (2251) operates in the Health Information Services industry and is headquartered in Beijing, China with about 181 employees. Its market capitalization is roughly CNY 909 million. In the fiscal year ended 2025-12-31, 2251 reported CNY 173M in revenue and (CNY 25M) in net income.

Beijing Airdoc Technology Co., Ltd. provides AI-empowered retina-based early detection, diagnosis, and health risk assessment solutions in Mainland China and internationally.

Interactive charts & full statements →

2251 Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-312022-12-312021-12-31
Total RevenueCNY 173MCNY 156MCNY 204MCNY 114M
Gross ProfitCNY 128MCNY 87MCNY 125MCNY 56M
Operating Income (EBIT)(CNY 28M)(CNY 199M)(CNY 184M)(CNY 234M)
Net Income(CNY 25M)(CNY 256M)(CNY 132M)(CNY 180M)

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

2251 Free Cash Flow History

2251 Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-312022-12-312021-12-31
Total AssetsCNY 1.3BCNY 1.4BCNY 1.7BCNY 1.7B
Total LiabilitiesCNY 88MCNY 135MCNY 127MCNY 69M

CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 2251 viewer.

Other Companies in Health Information Services

← 2250All “0-9” companies2252 →

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.